Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies

In Silico Pharmacology - Tập 8 Số 1
Opeyemi Iwaloye1, Olusola Olalekan Elekofehinti1, Emmanuel A. Oluwarotimi1, Babatom iwa Kikiowo1, Toyin Mary Fadipe1
1Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Ondo State, Nigeria

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ammon HP, Kelber O, Okpanyi SN (2006) Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle. Phytomed Suppl 5:67–74

Bertrand JA, Thieffine S, Vulpetti A et al (2003) Structural characterization of the GSK-β active site using selective and non-selective ATP-mimetic inhibitors. J Mol Bio 333(2):393–407

Beurel E (2011) Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases. Front Mol Neurosci 31(4):1–8

Buescher JL, Phiel CJ (2010) A non catalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activity. J Biol Chem 285:7957–7963

Cheng H, Woodgett J, Maamari M, Force T (2011) Targeting GSK-3 family members in the heart: a very sharp double-edged sword. J Mol Cell Cardiol 51:607–613

Cociova OM, Li B, NomanBhoy T, Li Q, Nakamura A, Nomura M, Okada K et al (2017) Synthesis and structure–activity relationship of 4-quinolone-3-carboxylic acid based inhibitors of glycogen synthase kinase-3β. Bioorg Mel Chem Lett 27(16):3733–3738

De Bondt HL, Rosenblatt J, Jancaric J, Jones HD, Morgan DO, Kim SH (1993) Crystal structure of cyclin-dependendkinase 2. Nature 363:595–602

de Oliveira MT, Katekawa E (2017) On the virtues of automated QSAR—the new kid on the block. Future Med Chem. https://doi.org/10.4155/FMC-2017-0170

Dixon SL, Duan J, Smith E, Von Bargen CD, Sherman W, Repasky MP (2016) AutoQSAR: an automated machine learning tool for best-practice quantitative structure–activity relationship modeling. Future Med Chem 8:1825–1839

Dorm GW (2005) 2nd, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Investig 115:527–537

Duan J, Dixon SL, Lowrie JF, Sherman W (2010a) Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods. J Mol Graph Model 29:157–170

Duan J, Dixon SL, Lowrie JF, Sherman W (2010b) Analysis and comparison of 2D fingerprints; insights into database screening performance using eight fingerprint method. J Mol Graph Model 29:157–170

Eldar-Finkelman H (2002) Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 8(1):26–32

Elekofehinti OO, Ejelonu O, Iwaloye O et al (2018) Discovery of potential visfatin activators using in silico docking and ADME predictions as therapy for type 2 diabetes. Beni Suef Univ J Basic Appl Sci 7(2):241–249

Gao X, Wang JY, Gao LM, Yin XF, Liu L (2013) Identification and analysis of glycogen synthase kinase 3 beta1 interactome. Cell Biol Int 37:768–779

Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Exp Opin Drug Discov 10:49–461. https://doi.org/10.1517/17460441.2015.1032936

Golbraikh A, Tropsha AJ (2002) Beware of q2! Mol Graph Mod 20:269–276. https://doi.org/10.1016/s1093-3263(01)00123-1

Gombar VK, Silver IS, Zhao Z (2003) Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability. Curr Top Med Chem 3(11):1205–1225. https://doi.org/10.2174/1568026033452014

Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA et al (2003) Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52:21–28

Heitz A, Carnat A, Fraisse D, Carnat AP, Lamaison JL (2000) Luteolin 3′-glucuronide, the major flavonoid from Melissa officinalis subsp. officinalis. Fitoterapia 71(2):201–202

Hsiung SC, Adlersberg M, Arango V, Mann JJ, Tamir H, Liu KP (2003) Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem 87:182–194. https://doi.org/10.1016/S0169-409X(00)00129-0

Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X et al (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3b to regulate cell growth. Cell 126:955–968

Iwaloye O, Elekofehinti OO, Babatomiwa K, Fadipe TM, Akinjiyan MO et al (2020a) Discovery of TCM derived compounds as wild type and mutant Plasmodium falciparum dihydrofolate reductase inhibitors: induced fit docking and ADME studies. Curr Drug Discov Technol. https://doi.org/10.2174/1570163817999200729122753

Iwaloye O, Elekofehinti OO, Oluwarotimi EA, Babatomiwa K, Momoh IA (2020b) In silico molecular studies of natural compounds as possible anti-Alzheimer’s agents: ligand-based design. Netw Model Anal Health Inform Bioinform 9:54. https://doi.org/10.1007/s13721-020-00262-7

Kamdem JP, Adeniran A, BoligonAA KCV, Elekofehinti OO, Hassane W, Ibrahimg M, Pansera WE, Meinerza DF, Athayde ML (2013) Antioxidant activity, genotoxicity and cytotoxicity evaluation of lemon balm (Melissa officinalis L.) ethanolic extract: its potential role in neuroprotection. Ind Crops Prod 51:26–34

Kapetanovic IM (2008) Computer-aided drug discovery and development (CADDD): in silico-chemicobiological approach. Chem Biol Interact 171:165–176

Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935–949

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1–3):3–26

Liu X (2014) Overstimulation can create health problems due to increases of PI/3K/Akt/GSK3 insensitivity and GSK3 activity. SpringerPlus 3:356

Liu Z, Liu Y, Zeng G, Shao B, Chen M, Li Z, Jiang Y, Liu Y, Zhang Y, Zhong H (2018) Application of molecular docking for the degradation of organic pollutants in the environmental remediation: a review. Chemosphere 203:139–150

Luo G, Chen L, Burton CR, Xiao H, Sivaprakasam P, Krause CM, Cao Y (2016) Discovery of isonicotinamides as highly selective, brain penetrable, and orally active glycogen synthase kinase-3 inhibitors. J Med Chem 59(3):1041–1051

Maffucci I, Hu X, Fumagalli V, Contini A (2018) An efficient implementation of the Nwat-MMGBSA method to rescore docking results in medium-throughput virtual screenings. Front Chem 6:43. https://doi.org/10.3389/fchem.2018.00043

Mancinelli R, Capino G, Petrungaro S, Mammola CL, Tomaipitinca L, Filippini A, Facchiano A, Ziparo E, Giampietri C (2017) Multifaceted roles of GSK-3 in cancer and autophagy-related diseases. Oxidative Med Cell Longev 2017:629495. https://doi.org/10.1155/2017/4629495

Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146–157

Moradkhani H, Sargsyan E, Bibak H, Naseri B, Sadat-Hosseini M, Fayazi-Barjin A, Meftahizade H (2010) Melissa officinalis L., a valuable medicine plant: a review. J Med Plants Res 4:2753–2759

Olesen PH, Sørensen AR, Ursø B, Kurtzhals P, Bowler AR, Ehrbar U, Hansen BF (2003) Synthesis and in vitro characterization of 1-(4-Aminofurazan-3-yl)-5-dialkylaminomethyl-1 H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors. J Med Chem 46(15):3333–3341

Olsson MHM, Søndergard CR, Rostkowski M, Jensen JH (2011) PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J Chem Theor Comput 7:525–537

Ożarowski M, Mikolajczak PL, Piasecka A, Kachlicki P, Kujawski R, Bogacz A, Bartkowiak-Wieczorek J, Szulc M, Kaminska E, Kujawska M, JodynisLiebert J, Gryszczynska A, Opala B, Lowicki Z, Seremak-Mrozikiewicz A, Czerny B (2016) Influence of the Melissa officinalisleaf extract on long-term memory in scopolamine animal model with assessment of mechanism of action. Evid Based Complement Altern Med. https://doi.org/10.1155/2016/9729818

Padavala A, Chitti S, Rajesh B, Vinukonda V, Jayanti R, Vali R (2010) In silico based ligand design and docking studies of GSK-3β inhibitors. Chem Bioinform J 10:1–12. https://doi.org/10.1273/cbij.10.1

Patora J, Klimek B (2002) Flavonoids from lemon balm (Melissa officinalis L., Lamiaceae). Acta Pol Pharm 59(2):139–143

Prime (2018) version 3.9, Schrodinger, LLC, New York

Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52:588–595

Robertson LA, Kim AJ, Werstuck GH (2006) Mechanisms linking diabetes mellitus to the development of atherosclerosis: a role for endoplasmic reticulum stress and glycogen synthase kinase-3. Can J Pharmacol 84(1):39–48. https://doi.org/10.1139/Y05-142

Sachs L (1984) Applied statistics: a handbook of techniques. Springer, Berlin

Saitoh M, Kunitomo J, Kimura E, Washita HI et al (2009) 2-{3-[4-(Alkylsulfinyl)phenyl]-1 -benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β with good brain permeability. J Med Chem 52(20):6270–6286

Sander T, Freyss J, von Korff M, Rufener C (2005) Datawarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55:460–473

Schrödinger Suite (2012) Protein Preparation Wizard; Epik version 2.3, Schrödinger, LLC, New York, NY, 2012; Impact version 5.8, Schrödinger, LLC, New York, NY, 2012; Prime version 3.1, Schrödinger, LLC, New York, NY, 2012.

Senderski ME (2009) Melisa lekarska, in: Zioła. Praktycznyporadnik o ziołachiziołolecznictwie. Wydawnictwo K.E. Liber. Warszawa, pp 422–426

Sherman W, Day T, Jacobson MP, Friesner RA, Farid R (2006) Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 49:534–553

Smith E, Frenkel B (2005) Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J Biol Chem 280:2388–2394

Smith DG, Buffet M, Fenwick AE, Haigh D, Ife RJ, Saunders M, Slingsby BP, Stacey R, Ward RW (2001) 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett 11:635–639

Sofowora A, Ogunbodede E, Onayade A (2013) The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 10:210–229

Sun H, Li Y, Shen M, Tian S, Xu L, Pan P et al (2014) Assessing the performance of the MM/PBSA and MM/GBSA methods. 5, improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. Phys Chem Chem Phys 1(6):22035–22045. https://doi.org/10.1039/c4cp03179b

Tagashira M, Ohtake Y (1998) New antioxidative 1,3-benzodioxole from Melissa officinalis. Planta Med 64(6):555–558

Takahashi YF, Sasaguri T (2009) Drug development targeting the glycogen synthasekinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci 109:179–183

Terrence LS, Andrew JP, Joyce AB, Scott D et al (2006) Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3. Bioorg Mel Chem Lett 16(18):2091–2094

Triantaphyllou K, Blekas G, Boskou D (2001) Antioxidative properties of water extracts obtained from herbs of the species Lamiaceae. Int J Food Sci Nutr 52(4):313–317

Witherington J, Bordas V, Gaiba A, Naylor A, Rawlings AD, Slingsby BP, Smith DG, TakleAK WRW (2003) 6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorg Med Chem Lett 13:3059–3062

Wold S, Ericksson L (1998) Partial least squares projections to latent structures (PLS) in chemistry. In: Ragu P, Schleyer P (eds) Encyclopedia of computational chemistry, vol 3. Wiley, Chichester, pp 2006–2021

Xie H, Wen H, Zhang D et al (2017) Designing of dual inhibitors for GSK-3beta and CDK5: virtual screening and in vitro biological activities study. Oncotarget 8(11):18118–18128

Xu C, Kim NG, Gumbiner BM (2009) Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 8:4032–4039

Yasri A, Hartsough DJ (2001) Toward an optimal procedure for variable selection and QSAR modeling building. Chem Inf Comput Sci 41:1218–1227. https://doi.org/10.1021/ci010291a

Yuki Y, Chikashi I (2015) Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Nat Sci Rep 5:13249. https://doi.org/10.1038/srep13249

Zarei A, Ashtiyani SC, Taheri S, Hosseini N (2015) A brief overview of the effects of Melissa officinalis L. extract on the function of various body organs. J Res Med Sci 17(7):1–6